Market Wire - Pharmaceuticals and Biotech: Biotech (Free subscription) | 02/12/2008
DUBLIN, IRELAND (MARKET WIRE) Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced significant cost reductions across its business enterprise.
ireland.com (Free subscription) | 02/12/2008
Trinity Biotech, the manufacturer of medical diagnostic kits, is to make 70 people redundant in a bid to cut costs.
Medical News Today (Free subscription) | 25/11/2008
Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the success of the clinical trials for the Destiny Max and the first orders for Destiny Max from Kyowa Medex, its distributor in Japan.
Market Wire (Free subscription) | 24/11/2008
DUBLIN, IRELAND (MARKET WIRE) Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the success of the clinical trials for the Destiny Max and the first orders for Destiny Max from Kyowa Medex, its distributor in Japan.
Market Wire - Pharmaceuticals and Biotech: Biotech (Free subscription) | 20/11/2008
DUBLIN, IRELAND (MARKET WIRE) Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced it has appointed Clint Severson to its Board as a non-executive director.
PR News Wire (Free subscription) | 20/11/2008
Commenting on the news, Tom Reidy stated, "We are delighted that Clint has agreed to serve as an independent director, bringing the total of independent directors to two. While Clint's appointment is a step in the right direction, we continue to believe that the election of an independent director controlled board is essential to an increase in company share value. We look forward to Clint remaining...
Market Wire (Free subscription) | 12/11/2008
DUBLIN, IRELAND (MARKET WIRE) Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced it has engaged William Blair International, Limited in connection with the Company's ongoing process to explore strategic alternatives to enhance shareholder value.
PR News Wire (Free subscription) | 11/11/2008
... of shareholders to consider a change in the board. This campaign follows the recent refusal by Trinity Biotech directors to honor an earlier request by a group of ADR holders for the calling of a special meeting of shareholders to consider the removal and replacement of the company's current directors. The directors' rejection of the request was based on their determination that ADRs have...
PR News Wire (Free subscription) | 07/11/2008
KANSAS CITY, Mo., Nov. 7 /PRNewswire/ -- In refusing to a request for a special shareholders meeting to consider the removal and replacement of its current directors, management of Trinity Biotech plc (Nasdaq: ), an Ireland-based developer and manufacturer of diagnostic products whose American Depository Receipts ("ADRs) are traded on NASDAQ, has apparently decided that the preservation of their...
Market Wire (Free subscription) | 31/10/2008
DUBLIN, IRELAND (MARKET WIRE) Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2008.
The Earth Times Online Newspaper (Free subscription) | 28/10/2008
KANSAS CITY, Mo., Oct. 27 /PRNewswire/ -- Thomas Reidy, an investor in Trinity Biotech plc (Nasdaq: TRIB), an Ireland-based developer and manufacturer of diagnostic products whose American Depository Receipts are ...
PR News Wire (Free subscription) | 28/10/2008
KANSAS CITY, Mo., Oct. 27 /PRNewswire/ -- Thomas Reidy, an investor in Trinity Biotech plc (Nasdaq: ), an Ireland-based developer and manufacturer of diagnostic products whose American Depository Receipts are traded on NASDAQ, will host an investor conference call November 3, 2008, at 10:00am EST, to discuss the recent shareholder proposal calling for the removal and replacement of ...
PR News Wire (Free subscription) | 23/10/2008
Conference Call Scheduled for October 31, 2008 at 11:00 am EASTERN DUBLIN, Ireland, Oct. 23 /PRNewswire-FirstCall/ -- Trinity Biotech plc (Nasdaq: ), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter of fiscal year 2008 on Friday, October 31, 2008. The Company has scheduled...
Independent.ie - European RSS Feed (Free subscription) | yesterday
... authorisation from the watchdog. to slash $6m costsMEDICAL DEVICESBray-based medical devices firm Trinity Biotech, which last week cut 11 jobs, said yesterday that it plans to slash $6m from its cost base next year. The Nasdaq-listed firm is facing a shareholder revolt from a -based activist group.BOW confirms Schulte dealTECHNOLOGYIrish firm Blue Ocean Wireless (BOW) confirmed yesterday...
